INS and fatty liver disease: Conversely, oral administration of DEFA5 suppressed ileal H. hepaticus and prevented endotoxemia, systemic inflammation and hepatic steatosis in the HFD+VDD mice, revealing a causal role of alpha-defensins in attenuating biogenesis of systemic inflammation, insulin resistance, and hepatic steatosis.